Azenta, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Azenta, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 7% in 3 years, but profit fell: $5,711 less profit per $100 of extra sales. Lower than almost all Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
1.2×Over the last 3 years its own operating cash covered its investment spending (capex) 1.2 times.
Higher than 69% of Healthcare companies in United States.
Cash Locked Ratio
$30For every $100 of sales, $30 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $30 tied up three years earlier.
More money tied up than 67% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$5,711Sales grew 7% in 3 years, but profit fell: $5,711 less profit per $100 of extra sales.
Lower than almost all Healthcare companies in United States.
Asset Productivity Ratio
+7% / -45%In 3 years sales changed by +7% while total assets changed by -45%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
+18%Cash, after subtracting all debt, equals 18% of its market value (net cash).
Higher than 61% of Healthcare companies in United States.
Tangible Assets Ratio
61%Of every $100 the company owns, $61 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 69% of Healthcare companies in United States.
Tangible Net Worth Ratio
53%Of every $100 of net worth, $53 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 50% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Azenta, Inc. made a loss over the last year. Azenta, Inc. owes $0.20 for every $1 it owns. Azenta, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Sep 2025.
P/E ratio
LossAzenta, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.04The share price is 1.04 times Azenta, Inc.'s book value per share, lower than 78% of Healthcare companies in United States.
Market cap
$1.6 BThe total market value of all of Azenta, Inc.'s shares at today's price (share price × number of shares), larger than 70% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$1.5 BWhat Azenta, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$34.47Net worth divided by the number of shares. The share price of $36.01 is 1.0 times this, which is the P/B above.
Return on equity (ROE)
-7.0%Azenta, Inc. lost 7.0% of its shareholders' money over the last year, higher than 73% of Healthcare companies in United States.
Owes vs Owns
0.20×Azenta, Inc. owes $0.20 for every $1 it owns (low), lower than 73% of Healthcare companies in United States.
Dividend yield
NoneAzenta, Inc. does not currently pay a dividend.
Revenue growth
+4%Revenue rose 4% in the year to Sep 2025, and grew 2% a year on average over 3 years.
Profit growth
LossAzenta, Inc. made a loss in each of the last two years.
Profit margin
-9.4%Azenta, Inc. lost $9 for every $100 of revenue.
Cash vs debt
Net cashAzenta, Inc. held $290 M more cash than debt (net cash) at Sep 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Azenta, Inc.: $1.6 B ÷ $1.5 B (30 Jun 2026) = 1.0.
What is Azenta, Inc.'s return on equity?
Azenta, Inc. lost 7.0% of its shareholders' money over the last year, higher than 73% of Healthcare companies in United States.
How much does Azenta, Inc. owe compared with what it owns?
Azenta, Inc. owes $0.20 for every $1 it owns (low), lower than 73% of Healthcare companies in United States.
Does Azenta, Inc. pay a dividend?
No. Azenta, Inc. does not currently pay a dividend.
Is Azenta, Inc.'s revenue growing?
Revenue rose 4% in the year to Sep 2025, and grew 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.